Product Portfolio
Mandi Product Portfolio
Hair Health (OTC)
Mandi® Minoxidil Foam 5%
Approval No.: H20234731
Generic Name: Minoxidil Foam
Specification: 60g × 1 Bottle, 5%
Category: OTC (Non-prescription)
The first and only minoxidil foam approved by the NMPA in China. Sales exceeded US$100 million in 2025.
Mandi® Minoxidil Tincture 5%
Approval No.: H20010714
Generic Name: Minoxidil Tincture
Specification: 5% × 60ml/90ml × 1 Bottle
Category: OTC (Non-prescription)
Ranked #1 in anti-hair loss and minoxidil markets for 10 consecutive years since 2014, with 75% market share.
Mandi® 2% Minoxidil Solution
Generic Name: Minoxidil Topical Solution
Specification: 2% Solution
Category: OTC (Non-prescription)
Formulated for female pattern hair loss, gentle and effective.
Consumer Cosmetics
Mandi Anti-Hair Loss & Strengthening Shampoo
Category: Cosmetic / Hair Care
Specialized shampoo for anti-hair loss and hair strengthening.
Mandi Repair & Volume Shampoo
Category: Cosmetic / Hair Care
Repairs damaged hair and adds volume.
Mandi Selenium Disulfide Anti-Dandruff Shampoo
Category: Cosmetic / Hair Care
Effective anti-dandruff shampoo with selenium disulfide.
Mandi Women's Oil Control & Volumizing Shampoo
Category: Cosmetic / Hair Care
Oil control and volumizing shampoo specially formulated for women.
Dermatology (Rx)
Laizi® Tacrolimus Ointment
Approval No.: H20133243
Generic Name: Tacrolimus Ointment
Specification: 10g:3mg (0.03%)
Category: Prescription (Rx)
For atopic dermatitis and facial melasma treatment. Available in 0.03% and 0.1% concentrations.
Other Prescription
Laiduofei® Fexofenadine Hydrochloride Tablets
Approval No.: H20060150
Generic Name: Fexofenadine Hydrochloride Tablets
Specification: 30mg × 28 Tablets
Category: Prescription (Rx)
Second-generation antihistamine for allergy relief.